北美医用大麻市场预测至 2028 年 - COVID-19 影响和区域分析 - 按产品类型（干燥形式和提取物形式）、应用（疼痛管理、图雷特氏症、阿尔茨海默氏病、偏头痛、抑郁和焦虑、多发性硬化症、癌症等）和分销渠道（零售药房、电子商务等）

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

No. of Pages: 127    |    Report Code: BMIRE00028793    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Medical Marijuana Market
Free Sample Buy Now

北美医用大麻市场预计将从2022年的71.7017亿美元增长到2028年的207.6041亿美元。预计2022年至2028年的复合年增长率为19.4%。   ; 

医用大麻产品审批的增加推动北美医用大麻市场的增长

< p>大麻的药用潜力吸引了各种研究人员和公司在医疗应用中使用大麻。例如，四氢大麻酚 (THC) 主要用于生产医药产品。美国食品和药物管理局 (FDA) 已批准基于 THC 的药品，例如 Cesamet，其活性成分为 naboline，是一种具有类似 THC 结构的合成衍生产品。 Cesamet 用于治疗接受化疗的患者的恶心。当其他药物无法控制恶心和呕吐时，通常会开出 Cesamet。 FDA 还批准 Marinol 和 Syndros 在美国用于治疗用途。 Marinol 和 Syndros 含有活性成分屈大麻酚——一种合成的 9-THC，被认为是大麻的精神活性成分。 Marinol 和 Syndros 药物用于刺激消耗综合症患者的食欲，消耗综合症是艾滋病的适应症之一。同样，各种基于大麻的产品已获得批准或正在进行临床试验。例如，nabiximols (Sativex) 是在加拿大批准商业化的药物。 Nabiximols 是一种大麻提取物，用于治疗与多发性硬化症相关的痉挛和神经性疼痛。它由 THC 和其他大麻二酚 (CBD) 组合配制而成。 2020年2月，加拿大公司CanaQuest Medical Corp向加拿大卫生部申请批准Mentabinol的生产和商业化。 Mentabinol 是一种基于 THC 的产品，其批准申请已根据《大麻法》提交。 FDA 对上述大麻产品的批准增加正在推动医用大麻市场的发展。

北美医用大麻市场概览

北美医用大麻市场分为美国、加拿大和墨西哥。据估计，医用大麻市场在美国占有最大份额。医用大麻市场的增长可归因于探索创新治疗应用的研究和合作不断增加、人们对医用大麻的认识不断提高以及该地区主要参与者的存在。此外，该地区不断增长的老龄化人口也将有利于市场的增长。

到2028年北美医用大麻市场收入和预测（美国）百万美元）

北美医用大麻市场细分

北美医用大麻市场分为产品类型、应用、分销渠道和国家。

根据产品类型，北美医用大麻市场分为干燥形式和提取物形式。 2022 年，提取物形式在北美医用大麻市场中占据较大份额。

根据应用，北美医用大麻市场分为疼痛管理、妥瑞氏症、阿尔茨海默病、偏头痛、抑郁症和焦虑症、多发性硬化症、癌症等。 2022年，疼痛管理细分市场在北美医用大麻市场中占据最大份额。

根据分销渠道，北美医用大麻市场分为零售药店、零售药店、零售药店和电子药店。 -商业及其他。 2022年，零售药房领域在北美医用大麻市场中占据最大份额。

按国家划分，北美医用大麻市场分为美国、加拿大、和墨西哥。 2022 年，美国将主导北美医用大麻市场。

Aphria, Inc.; CanaQuest 医疗公司； Canopy Growth 公司；翡翠健康治疗公司； GW 制药公司；马里坎公司； Organigram 控股公司；帕纳夏制药工业有限公司；菲娜控股公司；和 VIVO Cannabis Inc 是北美医用大麻市场的领先公司。   

Identical Market Reports with other Region/Countries

The List of Companies - North America Medical Marijuana Market

  1. Aphria, Inc.
  2. CanaQuest Medical Corporation
  3. Canopy Growth Corporation
  4. Emerald Health Therapeutics Inc.
  5. GW Pharmaceuticals
  6. MARICANN INC.
  7. Organigram Holdings Inc.
  8. Panaxia Pharmaceutical Industries Ltd.
  9. Phoena Holdings Inc.
  10. VIVO Cannabis Inc
Frequently Asked Questions
How big is the North America Medical Marijuana Market?

The North America Medical Marijuana Market is valued at US$ 7,170.17 Million in 2022, it is projected to reach US$ 20,760.41 Million by 2028.

What is the CAGR for North America Medical Marijuana Market by (2022 - 2028)?

As per our report North America Medical Marijuana Market, the market size is valued at US$ 7,170.17 Million in 2022, projecting it to reach US$ 20,760.41 Million by 2028. This translates to a CAGR of approximately 19.4% during the forecast period.

What segments are covered in this report?

The North America Medical Marijuana Market report typically cover these key segments-

  • Product Type (Dried Form, Extract Form)
  • Application (Pain Management, Tourette's, Alzheimer's Disease, Migraines, Depression and Anxiety, Multiple Sclerosis, Cancer)
  • Distribution Channel (Retail Pharmacy, E-Commerce)

    • What is the historic period, base year, and forecast period taken for North America Medical Marijuana Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Medical Marijuana Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
    • Who are the major players in North America Medical Marijuana Market?

    The North America Medical Marijuana Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Aphria, Inc.
  • CanaQuest Medical Corporation
  • Canopy Growth Corporation
  • Emerald Health Therapeutics Inc.
  • GW Pharmaceuticals
  • MARICANN INC.
  • Organigram Holdings Inc.
  • Panaxia Pharmaceutical Industries Ltd.
  • Phoena Holdings Inc.
  • VIVO Cannabis Inc
    • Who should buy this report?

    The North America Medical Marijuana Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the North America Medical Marijuana Market value chain can benefit from the information contained in a comprehensive market report.

    north-america-medical-marijuana-market